Publication - Research and analysis

Opioid Substitution Therapy (OST) implicated deaths and prescribing: evidence review

This paper summarises current knowledge of trends around methadone and buprenorphine related deaths and changes to prescribing practice in Scotland.

Appendix 1. DRDs and Methadone-implicated death by local authority and NHS Health Board, 2020.

Table. 2. DRDs by council area, 2020
Council area	All DRDs	Methadone-implicated	%
Aberdeen City	56	35	62.5
Aberdeenshire	33	13	39.4
Angus	14	6	42.9
Argyll & Bute	16	7	43.8
City of Edinburgh	92	51	55.4
Clackmannanshire	9	3	33.3
Dumfries & Galloway	22	15	68.2
Dundee City	57	30	52.6
East Ayrshire	36	19	52.8
East Dunbartonshire	14	6	42.9
East Lothian	14	7	50.0
East Renfrewshire	10	5	50.0
Falkirk	37	19	51.4
Fife	65	38	58.5
Glasgow City	291	177	60.8
Highland	33	12	36.4
Inverclyde	33	16	48.5
Midlothian	21	10	47.6
Moray	10	6	60.0
Na h-Eileanan Siar	3	0	0.0
North Ayrshire	39	21	53.8
North Lanarkshire	94	40	42.6
Orkney Islands	3	0	0.0
Perth & Kinross	34	25	73.5
Renfrewshire	67	27	40.3
Scottish Borders	18	7	38.9
Shetland Islands	4	1	25.0
South Ayrshire	31	14	45.2
South Lanarkshire	91	53	58.2
Stirling	31	18	58.1
West Dunbartonshire	29	17	58.6
West Lothian	32	10	31.3
Scotland	1,339	708	52.9

Table 3. DRDs by NHS Health Board, 2020
NHS Health Board	All DRDs	Methadone-implicated	%
Ayrshire & Arran	106	54	50.9
Borders	18	7	38.9
Dumfries & Galloway	22	15	68.2
Fife	65	38	58.5
Forth Valley	77	40	51.9
Grampian	99	54	54.5
Greater Glasgow & Clyde	444	248	55.9
Highland	49	19	38.8
Lanarkshire	185	93	50.3
Lothian	159	78	49.1
Orkney	3	0	0.0
Shetland	4	1	25.0
Tayside	105	61	58.1
Western Isles	3	0	0.0
Scotland	1,339	708	52.9

Thanks for your feedback